相关实验视频

Updated: Sep 17, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

合成,分子对接,分子动态模拟和生物评估新型3,4-二二二衍生物作为强大的抗结核剂

Riya Khandelwal¹, Mahesh Vasava², Vijay Kevlani¹

¹School of Pharmacy, National Forensic Sciences University, Gandhinagar, Gujarat, India.

Molecular diversity

|July 1, 2025

概括

新的二皮里丁衍生物在打击抗生素耐药性方面表现有前途. 这些化合物表现出显著的抗菌和抗结核活性,针对潜在的新治疗方法的重要细菌酶.

科学领域:

药用化学医学化学
药物发现药物发现药物发现
抗微生物耐药性抗微生物耐药性

背景情况:

抗生素耐药性对全球健康构成重大威胁,需要开发新型治疗剂.
二氨酸衍生物因其潜在的抗菌性质而被探索.

研究的目的:

合成和评估新型3,4-二皮里米丁衍生物的抗结核和抗菌潜力.
为了确定有前途的药物候选人来对抗耐药细菌菌株.

主要方法:

使用Biginelli凝结合成二皮里米丁衍生物 (4a-4m) 的合成.
使用光谱技术 (FT-IR,MS,NMR) 和差分扫描热量计进行结构性表征.
在体外抗菌和抗结核测定,ADMET查,对DprE1进行分子对接,以及分子动力学模拟.

主要成果:

八种化合物 (4c,4e,4f,4g,4i,4j,4k,4m) 显示出有利的ADMET概况.
化合物4g,4d,4e和4c对DprE1目标表现出强烈的结合亲和力.
分子动力学模拟证实了稳定的蛋白质-配体相互作用.
合成的化合物表现出显著的抗菌活性和中度到显著的体外抗结核疗效对H37Rv菌株.

结论:

合成的二皮里米丁衍生物显示出作为新型抗菌和抗结核剂的潜力.
具有对DprE1有前途活性的化合物需要进一步研究,作为结核病治疗的候选药物.

关键词:

具有抗菌活性,具有抗菌活性.它具有抗结核活性.比吉内利反应是比吉内利反应.二皮里米丁衍生物二皮里米丁衍生物异环化合物异环化合物分子对接是分子对接.

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...